![R. Elsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
R. Elsey
Directeur/Membre du Conseil chez
REGENERX BIOPHARMACEUTICALS, INC.
Fortune : 2 132 $ au 31/05/2026
Profil
R.
Donald Elsey currently works at RegeneRx Biopharmaceuticals, Inc., as Independent Director from 2010, Cancer Support Community, as Treasurer & Director, Learning Undefeated, Inc., as Director from 2010, and BullFrog AI Holdings, Inc., as Independent Non-Executive Director from 2023.
Mr. Elsey also formerly worked at Applera Corp., as Finance Director, BioVeris Corp., as Director-Finance & Administration from 2000 to 2005, IGEN International, Inc., as Director-Finance & Administration from 2000 to 2005, CapForce, Inc., as Independent Director from 2019 to 2024, LifeCell Corp., as Chief Financial Officer from 2012 to 2014, Regado Biosciences, Inc., as Chief Financial Officer & Senior Vice President from 2014 to 2015, Senseonics, Inc., as Chief Financial Officer from 2015 to 2019, Emergent BioSolutions, Inc., as CFO, Treasurer, SVP-Finance & Administration from 2005 to 2012, Lyra Therapeutics, Inc., as Chief Financial Officer, Secretary & Treasurer from 2019 to 2021, and Senseonics Holdings, Inc., as Chief Financial Officer, Secretary & Treasurer from 2015 to 2019.
Mr. Elsey received his undergraduate degree and Masters Business Admin degree from Michigan State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 2 813 ( 0,02 % ) | 2 132 $ | 31/05/2026 |
Postes actifs de R. Elsey
| Sociétés | Poste | Début |
|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/09/2010 |
| BULLFROG AI HOLDINGS, INC. | Directeur/Membre du Conseil | 14/02/2023 |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | 12/01/2010 |
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Directeur/Membre du Conseil | 01/01/2012 |
Anciens postes connus de R. Elsey
| Sociétés | Poste | Fin |
|---|---|---|
| CAPFORCE INC. | Directeur/Membre du Conseil | 25/03/2024 |
| LYRA THERAPEUTICS, INC. | Directeur Financier/CFO | 13/09/2021 |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Directeur Financier/CFO | 01/02/2019 |
| SENSEONICS HOLDINGS, INC. | Directeur Financier/CFO | 07/01/2019 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Directeur Financier/CFO | 06/02/2015 |
Formation de R. Elsey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
RegeneRx Biopharmaceuticals, Inc.
 RegeneRx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and markets novel therapeutic peptide for tissue and organ protection, repair & regeneration | Health Technology |
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology Develops and markets tissue repair products | Health Technology |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
OpGen, Inc.
 OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Senseonics Holdings, Inc.
 Senseonics Holdings, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Commercial Services |
BullFrog AI Holdings, Inc.
 BullFrog AI Holdings, Inc. Packaged SoftwareTechnology Services Develops an artificial intelligence and machine learning platform for clinical and pharmaceutical industry | Technology Services |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
